The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Spring 2025 RFA: Molecular MRI Biomarker Program, 2026MR Imaging of Immunomodulation in Parkinson’s Disease
Study Rationale:
Brain inflammation contributes to progression of Parkison’s Disease (PD), and drugs targeting inflammation are being developed as disease modifying treatments for PD...
-
Research Grant, 2026Multimodal Machine Learning Models for Predicting Lewy Body Pathology Using Post-mortem Brain Data
Study Rationale:
Parkinson’s disease and Lewy body disease share many clinical and biological features, which makes it difficult to distinguish between them with current diagnostic tools. This lack of...
-
T2T Validation - Endolysosomal Targets, 2026Toward an Atlas of Endolysosomal System Dysfunction with PD-associated Channels/Transporters
Study Rationale:
TMEM175 and ATP13A2 have been identified as risk genes for Parkinson’s disease. These proteins function to transport protons and polyamines through the lysosomal...
-
Fall 2025 RFP: Data Advice To Action, 2026Multi-resolution Pathway-centric Biomarker Discovery for Parkinson’s Disease Diagnosis, Prognosis, Progression, and Treatment Recommendations
Study Rationale:
Parkinson’s disease (PD) is difficult to diagnose early and to distinguish from related synucleinopathies such as DLB and MSA. Although single-nucleus RNA sequencing...
-
Research Grant, 2026Deep Mutational Scanning of TMEM175
Study Rationale:
Parkinson’s disease develops through a combination of ageing, environmental factors, and genetic risk. One gene linked to Parkinson’s is TMEM175, which encodes an...
-
Research Grant, 2026Cell Type Meta-eQTL Study in Human Brains
Study Rationale:
Parkinson’s (PD) genome-wide association study (GWAS) with ~1.5 million subjects identified 90 PD risk signals with ~7,000 non-coding PD...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.